Cardiovascular Risk Up With Metabolic Syndrome in Psoriasis
WEDNESDAY, Dec. 30, 2020 -- Metabolic syndrome (MetSyn) is prevalent among patients with psoriasis and is associated with increased cardiovascular risk, according to a study published online Dec. 28 in the Journal of the American Academy of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Academies | Cardiology | Cardiovascular | Heart | Metabolic Syndrome | Pharmaceuticals | Psoriasis | Study